Acceptability and Tolerance Study of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children

Sponsor
Nestlé (Industry)
Overall Status
Completed
CT.gov ID
NCT04515940
Collaborator
(none)
21
1
11
1.9

Study Details

Study Description

Brief Summary

This is an acceptability study (including gastrointestinal tolerance, compliance and palatability) of a high energy peptide based paediatric oral nutritional supplement for children over 12 months of age.

The acceptability data from a minimum of 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: acceptability, tolerance and palatability study

Detailed Description

Fifteen (15) participants, aged 12 months and over, requiring a high energy peptide based oral nutritional supplement drink for the dietary management.

The ACBS requirement for evaluable data on 15 participants has informed the trial's recruitment target; however, we may need to exceed this target if any patients give their consent to join the study but then decide not to participate in the study. Participants who join the study and begin using the product would count towards the recruitment total and their data would be included in a submission to the ACBS whether they complete the 7-day study period or not.

Each potential participant must meet all of the inclusion criteria and not meet any of the exclusion criteria.

Study Design

Study Type:
Observational
Actual Enrollment :
21 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Evaluation of the Acceptability (Including Gastrointestinal Tolerance, Compliance and Palatability) of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children Over 12 Months of Age
Actual Study Start Date :
Oct 30, 2019
Actual Primary Completion Date :
Sep 29, 2020
Actual Study Completion Date :
Sep 29, 2020

Outcome Measures

Primary Outcome Measures

  1. Gastrointestinal tolerance [Day 7 from baseline]

    Daily record via participant diary: Gastrointestinal tolerance: Diarrhoea and / or constipation Bloating and / or distension Nausea and / or vomiting Burping / flatulence / regurgitation Abdominal discomfort / pain/ back arching/ crying Participant compliance: How many feeds taken and volume prescribed each day Acceptability Questionnaires to children and or parents for the evaluation of the acceptability and ease of use of the milk supplement drink Diarrhoea, constipation, bloating, distension, nausea, vomitting, burping, abdominal pain

  2. Compliance [Day 7 from baseline]

    volume suggested versus consumed

Secondary Outcome Measures

  1. weight in kg [Day 8 from baseline]

    At baseline

  2. height in meters [Day 8 from baseline]

    At basline

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Children aged 1 year and over who require 1-3 bottles of an oral nutritional peptide based supplement drink II. Children who require an oral nutritional supplement or who are already established on a nutritional supplement drink III. Children who require a nutritional supplement drink as bolus feeding via a feeding tube.

  2. Children being able to communicate views of acceptability V. Willingly given, written, informed consent from patient or parent/guardian. VI. Willingly given, written assent (if appropriate).

Exclusion Criteria:
  1. Inability to comply with the study protocol, in the opinion of the investigator.

  2. Contraindications to any feed ingredients (see nutritional table and ingredients list)

  3. Require a milk free diet IV. Children under the age of 12 months V. Emergencies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nutrition and Dietetics Brighton Sussex United Kingdom BN2 5BE

Sponsors and Collaborators

  • Nestlé

Investigators

  • Principal Investigator: Chris Smith, Nutrition and Dietetics

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nestlé
ClinicalTrials.gov Identifier:
NCT04515940
Other Study ID Numbers:
  • ONS peptide 1.5
First Posted:
Aug 17, 2020
Last Update Posted:
Nov 5, 2020
Last Verified:
Mar 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2020